Prognostic value of visfatin in various human malignancies: A systematic review and meta-analysis.

Mohammadi, Masoumeh; Moradi, Ali; Farhadi, Javad; Akbari, Abolfazl; Pourmandi, Shokoufeh; Mehrad-Majd, Hassan

Mohammadi, Masoumeh; Moradi, Ali; Farhadi, Javad; Akbari, Abolfazl; Pourmandi, Shokoufeh; Mehrad-Majd, Hassan.

Afiliación

Mohammadi M; Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Moradi A; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Farhadi J; Department of Biochemistry and Molecular Biology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.
Akbari A; Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
Pourmandi S; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mehrad-Majd H; Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Mehradmajdh@mums.ac.ir.

Cytokine ; 127: 154964, 2020 03.

Article en En | MEDLINE | ID: mdl-31901760

Asunto(s)

Neoplasias/metabolismo; Neoplasias/patología; Nicotinamida Fosforribosiltransferasa/metabolismo; Animales; Biomarcadores de Tumor/metabolismo; Humanos; Metástasis Linfática/patología; Pronóstico

Palabras clave

Cancer; Meta-analysis; Prognostic marker; Visfatin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nicotinamida Fosforribosiltransferasa / Neoplasias Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Cytokine Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google